Buscar
Mostrando ítems 1-10 de 72
Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
(European Respiratory Society, 2021)
Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
(European Respiratory Society, 2022)
Encapsulation of the Antimicrobial and Immunomodulator Agent Nitazoxanide Within Polymeric Micelles
(American Scientific Publishers, 2014-06)
Nitazoxanide (NTZ) is a highly hydrophobic nitrothiazolyl-salicylamide that displays antimicrobial activity against a variety of parasites, anaerobic bacteria and viruses. More recently, its effectiveness in the pharmacotherapy ...
Nanodelivery of nitazoxanide: Impact on the metabolism of Taenia crassiceps cysticerci intracranially inoculated in mice
(Future Medicine, 2020-05)
To formulate nanocapsules and nanoemulsions of nitazoxanide (NTZ) and evaluate the metabolic effect on Taenia crassiceps cysticerci inoculated intracranially into mice. Materials & methods: NTZ nanosystems were formulated ...
Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series
(PAGEPress srl, Italy, 2022)
Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
(European Respiratory Society, 2021)
Nitazoxanide is widely available and exerts broad-spectrum antiviral activity in vitro. However, there is no evidence of its impact on SARS-CoV-2 infection. In a multicenter, randomised, double-blind, placebo-controlled ...